DSM Capital Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.04M Sell
25,544
-3,383
-12% -$1.07M 0.14% 34
2026
Q1
$9.51M Buy
28,927
+10,021
+53% +$3.6M 0.17% 30
2025
Q4
$6.64M Buy
18,906
+175
+0.9% +$63.8K 0.1% 27
2025
Q3
$6.92M Buy
18,731
+14,225
+316% +$5.5M 0.1% 28
2025
Q2
$1.78M Buy
4,506
+749
+20% +$280K 0.03% 33
2025
Q1
$1.4M Buy
3,757
+468
+14% +$178K 0.02% 36
2024
Q4
$1.18M Buy
3,289
+2,572
+359% +$953K 0.02% 38
2024
Q3
$259K Buy
717
+545
+317% +$188K ﹤0.01% 40
2024
Q2
$58.5K Hold
172
﹤0.01% 58
2024
Q1
$61.6K Buy
172
+60
+54% +$20.2K ﹤0.01% 65
2023
Q4
$33.5K Buy
+112
New +$31.4K ﹤0.01% 83
2021
Q1
Sell
-45,950
Closed -$11.3M 72
2020
Q4
$11.3M Sell
45,950
-1,869
-4% -$423K 0.12% 32
2020
Q3
$9.96M Buy
+47,819
New +$9.3M 0.11% 30
2019
Q2
Sell
-4,600
Closed -$909K 56
2019
Q1
$909K Buy
4,600
+1,650
+56% +$297K 0.01% 41
2018
Q4
$463K Buy
+2,950
New +$493K 0.01% 45

Other funds holding SYK

DSM Capital Partners's SYK Position: Q2 2026 in Review

DSM Capital Partners reduced its Stryker (SYK) stake by 12% in Q2 2026, selling an estimated $1.07M and leaving 25,544 shares worth $8.04M. The position accounts for 0.14% of the portfolio, ranked #34.

DSM Capital Partners first reported a position in SYK in Q4 2018 and has held it in 15 quarters since. The position peaked at $11.3M in Q4 2020. 2,257 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • DSM Capital Partners held 25,544 shares of Stryker worth $8.04M as of Q2 2026.
  • DSM Capital Partners sold 3,383 Stryker shares in Q2 2026, an estimated $1.07M.
  • Stryker made up 0.14% of DSM Capital Partners's portfolio in Q2 2026, its #34 holding.
  • DSM Capital Partners first reported a position in Stryker in Q4 2018 and has held it in 15 quarters since.
  • DSM Capital Partners's Stryker position peaked at $11.3M in Q4 2020.
  • 2,257 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on DSM Capital Partners's 13F filing for Q2 2026, filed 3 Aug 2026.